APA način citiranja

Doms, J., Prior, J., Peters, S., & Obeid, M. (2020). Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis. Ann Oncol.

Čikaški stil citiranja

Doms, J., J.O Prior, S. Peters, i M. Obeid. "Tocilizumab for Refractory Severe Immune Checkpoint Inhibitor-associated Myocarditis." Ann Oncol 2020.

MLA način citiranja

Doms, J., J.O Prior, S. Peters, i M. Obeid. "Tocilizumab for Refractory Severe Immune Checkpoint Inhibitor-associated Myocarditis." Ann Oncol 2020.